Advertisement

Life-Sciences-Asia.com
The East-West Life Sciences Web Portal
This is a free web portal for the life sciences in Asia-Pacific, Europe and North America... » read more
- Sphere Bio Expands Operations in China (2025-06-17)
> Exclusive agreement with specialist biotechnology distributor, Redbert Biotechnology, to strengthen international growth and market penetration. > Johnathan Fu appointed as Country Manager to lead regional partnerships and enhance customer support. [photo... - AstraZeneca: up to $5,33b Strategic Collaboration with CSPC (2025-06-13)
AstraZeneca has entered a strategic research collaboration with Shijiazhuang City-based CSPC Pharmaceuticals Group Limited. Working together on high priority targets, the collaboration aims to advance the discovery and development of novel oral candidates, with the... - BioNTech to Acquire CureVac for $1.25b in Shares (2025-06-12)
> Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key milestone in the execution of its oncology strategy > Acquisition of CureVac will comple... - Mosanna Therapeutics Launches with $80m Series A Round (2025-06-09)
> Series A funding to advance MOS118 through Phase 2 clinical trials > Biotech veteran David Weber appointed CEO to drive clinical development > Obstructive sleep apnea affects nearly 1 billion people globally, with the majority undiagnosed and underserved wi... - BioNTech & BMS: up to $11.1b for Bispecific Antibody BNT327 (2025-06-02)
> BNT327, BioNTech’s PD-L1xVEGF-A bispecific antibody, is a clinically advanced investigational immunotherapy candidate with the potential to surpass current checkpoint inhibitor outcomes and set a new standard of care in multiple tumor types > The co-developm... - GlycoEra AG Raises $130m Series B Led by Novo Holdings (2025-05-27)
> Financing led by Novo Holdings with significant support from world-class group of existing and new investors > Proceeds from financing to support development of first-in-class IgG4-targeted protein degrader program through clinical proof-of-concept and the co... - PeptiSystems & Asahi Kasei Partner for Peptide Synthesis (2025-05-15)
PeptiSystems, a biotech company specializing in innovative manufacturing solutions for peptide and oligonucleotide drugs, has formed an exclusive global partnership with Asahi Kasei Bioprocess America (AKBA), a leading provider of advanced bioprocessing equipment s... - Lonza: Andreas Bohrer New Chief Legal & CorpAffairs Officer (2025-05-15)
> Andreas Bohrer has served as Lonza’s Group General Counsel and Company Secretary since 2015 > As of 1 July 2025, Andreas joins Lonza’s Executive Committee as Chief Legal & Corporate Affairs Officer > Andreas also represents Lonza as the Chair of Swiss... - Agilent Partners with Ubix Therapeutics for Cancer Research (2025-05-14)
Research focuses on targeted protein degradation and antibody-drug conjugate as promising modalities for developing next-generation cancer therapies that may improve patient outcomes Agilent Technologies Inc. (NYSE: A) announced the recent signing of a Memoran... - Agilent Inaugurates India Solution Center in Manesar (2025-05-08)
Integrated Facility to Deliver End-to-End, Customized Workflows Across Life Sciences, Diagnostics, and Applied Markets Agilent today announced the opening of its first-ever India Solution Center at its LEED Platinum-certified office in Manesar, Haryana. Design...
Life-Sciences-Asia.com is your doorway to the East-West life sciences!
[LSA] provides free, up-to-date and structured access to
– News
– Products
– Persons
– Organisations
– Financings
– Collaborations
in the Asia-Pacific, Europe and North America regions.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSA] is 100% Made in Europe!
» Start here with the latest News!Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top